74493 Evaluation of a Topical Formulation combining Aspalathus linearis and Polypodium leucotomos extracts in the prevention of skin hyperpigmentation and molecular alterations induced by visible light
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB212
DOI: 10.1016/j.jaad.2026.04.862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Sergio Schalka und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schalka, S., Sabrina, M., Shafiq, A., VITALE, M., & Gonzalez, S. (2026). 74493 Evaluation of a Topical Formulation combining Aspalathus linearis and Polypodium leucotomos extracts in the prevention of skin hyperpigmentation and molecular alterations induced by visible light. Journal of the American Academy of Dermatology, 95(1), AB212. https://doi.org/10.1016/j.jaad.2026.04.862
Vancouver
Schalka S, Sabrina M, Shafiq A, VITALE M, Gonzalez S. 74493 Evaluation of a Topical Formulation combining Aspalathus linearis and Polypodium leucotomos extracts in the prevention of skin hyperpigmentation and molecular alterations induced by visible light. Journal of the American Academy of Dermatology. 2026;95(1):AB212. doi:10.1016/j.jaad.2026.04.862
BibTeX
@article{Schalka2026,
author = {Schalka, Sergio and Sabrina, Michelle and Shafiq, Alia and VITALE, M.A.R.I.A. and Gonzalez, Salvador},
title = {74493 Evaluation of a Topical Formulation combining Aspalathus linearis and Polypodium leucotomos extracts in the prevention of skin hyperpigmentation and molecular alterations induced by visible light},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB212},
doi = {10.1016/j.jaad.2026.04.862}
}
EUVIMED